ROYALTY PHARMA OA DL-0001ROYALTY PHARMA OA DL-0001ROYALTY PHARMA OA DL-0001

ROYALTY PHARMA OA DL-0001

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
0.92EUR
Revenue estimate
‪616.84 M‬EUR
Market capitalization
‪15.78 B‬EUR
‪1.03 B‬EUR
‪2.13 B‬EUR
‪383.02 M‬
Beta (1Y)
0.76

About Royalty Pharma plc

CEO
Pablo Gerardo Legorreta
Headquarters
New York
Employees (FY)
89
Founded
2020
ISIN
GB00BMVP7Y09
FIGI
BBG00WR7W0D4
Royalty Pharma Plc provides drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RPD is 25.93 EUR — it has increased by 0.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ROYALTY PHARMA OA DL-0001 stocks are traded under the ticker RPD.
ROYALTY PHARMA OA DL-0001 is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
RPD stock is 0.62% volatile and has beta coefficient of 0.76. Check out the list of the most volatile stocks — is ROYALTY PHARMA OA DL-0001 there?
RPD earnings for the last quarter are 0.75 EUR per share, whereas the estimation was 0.73 EUR resulting in a 2.49% surprise. The estimated earnings for the next quarter are 0.92 EUR per share. See more details about ROYALTY PHARMA OA DL-0001 earnings.
ROYALTY PHARMA OA DL-0001 revenue for the last quarter amounts to ‪602.60 M‬ EUR despite the estimated figure of ‪597.62 M‬ EUR. In the next quarter revenue is expected to reach ‪621.09 M‬ EUR.
Yes, you can track ROYALTY PHARMA OA DL-0001 financials in yearly and quarterly reports right on TradingView.
RPD stock has risen by 0.31% compared to the previous week, the month change is a 6.86% fall, over the last year ROYALTY PHARMA OA DL-0001 has showed a 17.21% decrease.
RPD net income for the last quarter is ‪448.48 M‬ EUR, while the quarter before that showed ‪68.22 M‬ EUR of net income which accounts for 557.40% change. Track more ROYALTY PHARMA OA DL-0001 financial stats to get the full picture.
Today ROYALTY PHARMA OA DL-0001 has the market capitalization of ‪11.83 B‬, it has increased by 1.00% over the last week.
Yes, RPD dividends are paid quarterly. The last dividend per share was 0.19 EUR. As of today, Dividend Yield (TTM)% is 2.88%. Tracking ROYALTY PHARMA OA DL-0001 dividends might help you take more informed decisions.
ROYALTY PHARMA OA DL-0001 dividend yield was 2.85% in 2023, and payout ratio reached 31.57%. The year before the numbers were 1.92% and 777.10% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, RPD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ROYALTY PHARMA OA DL-0001 stock right from TradingView charts — choose your broker and connect to your account.
RPD reached its all-time high on Jul 18, 2022 with the price of 44.60 EUR, and its all-time low was 24.04 EUR and was reached on Nov 30, 2023.
See other stocks reaching their highest and lowest prices.
As of May 1, 2024, the company has 89.00 employees. See our rating of the largest employees — is ROYALTY PHARMA OA DL-0001 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ROYALTY PHARMA OA DL-0001 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ROYALTY PHARMA OA DL-0001 stock shows the sell signal. See more of ROYALTY PHARMA OA DL-0001 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ROYALTY PHARMA OA DL-0001 future price: according to them, RPD price has a max estimate of 46.64 EUR and a min estimate of 34.51 EUR. Read a more detailed ROYALTY PHARMA OA DL-0001 forecast: see what analysts think of ROYALTY PHARMA OA DL-0001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ROYALTY PHARMA OA DL-0001 EBITDA is ‪1.35 B‬ EUR, and current EBITDA margin is 63.37%. See more stats in ROYALTY PHARMA OA DL-0001 financial statements.